Upcoming BrightFocus Chats

BrightFocus ChatsSM are a monthly series of telephone discussions with health experts who take questions from call participants on vision diseases, such as macular degeneration.

The Chats are provided for patients and loved ones who have many unanswered questions and fears, and with little time to address them all in the doctor’s office.

You can access the telephone discussions by registering below or by calling 1-877-229-8493 at 1 p.m. Eastern on the day of the Chat and using the ID code 112435.

Coming Up Next

Past Chats

Keeping Your Eyes Healthy in the New Year (January 2020)

January 29, 2020

Yasha Modi, MD is an Assistant Professor in the Department of Ophthalmology at NYU Langone Health and is a vitreoretinal surgeon at Tisch Hospital and the Ambulatory Care Center. He treats people who have diseases that affect the vitreous—a clear substance in the eye—the retina, and the choroid—the layer of the eye containing blood vessels and connective tissue. In addition to caring for patients, he also performs research to understand retinal vascular diseases, including diabetes and vein occlusion, retinal drug toxicity, age-related macular degeneration, and the outcomes of retinal detachment surgery.


Listen to the discussion:

Update on AMD Treatments

November 20, 2019

The discussion features Edward Marcus, MD, from SightMD in Brentwood, New York. Dr. Marcus specializes in medical and surgical management of retinal diseases, including diabetic retinopathy, macular degeneration, and retinal detachment. He also specializes in treating inflammatory and infectious eye diseases.


Listen to the discussion:

Nutritional Supplements, Dietary Patterns, and Age-Related Macular Degeneration

October 23, 2019

The telephone discussion features Emily Y. Chew, MD, who is a retina specialist and is the deputy director of the Division of Epidemiology and Clinical Applications, and the deputy clinical director at the National Eye Institute (NEI), National Institutes of Health (NIH). Dr. Chew has extensive experience in age-related eye diseases, and designing and implementing clinical trials, including the Age-Related Eye Disease Study 2 (AREDS2).


Listen to the discussion:

Don't miss out.
Receive research updates, inspiring stories, and expert advice
Please enter your first name.
Please enter your last name.
Keep me informed about: *
Please select at least one.
You must select at least one disease category.